Revance Therapeutics Inc (FRA:RTI)
€ 3.4 -0.1 (-2.86%) Market Cap: 371.12 Mil Enterprise Value: 655.05 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 68/100

Revance Therapeutics Inc Annual Shareholders Meeting Transcript

May 14, 2020 / 03:00PM GMT
Release Date Price: €17.4 (-10.77%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Revance Therapeutics Annual Meeting.

(Operator Instructions) I would now like to hand the call over to our host, Angus Russell. Please go ahead. Angus?

Angus C. Russell
Revance Therapeutics, Inc. - Independent Chairman

Good morning, ladies and gentlemen.

I'm Angus Russell, Chairman of the Board of Revance Therapeutics, Inc.

I want to welcome you to our 2020 shareholders' meeting. We are pleased you could be with us today, virtually only as a result of concerns over the coronavirus situation. Additional benefits of hosting a virtual meeting allows us to provide expanded access, improved communication and cost savings for our stockholders. Virtual meetings are a highly efficient way to enable shareholders to attend shareholder meetings without incurring the expense and inconvenience of traveling to the meeting site, thereby allowing the company to directly communicate with a larger shareholder audience than the traditional in-person meeting. Stockholders who are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot